Scilex Holding Co. (SCLX) intrinsic value & 10-year financials

Scilex Holding Co. (SCLX) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 7 fiscal years revenue grew 5.1% a year to $30.3M, with an average return on invested capital of 62.5%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$2.83
Market cap
$31.2K
Revenue (FY2025)
$30.3M
Revenue growth (7-yr CAGR)
5.1%
ROIC (10-yr avg)
62.5%
Free cash flow (FY2025)
$3.7M

SCLX 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $30.3M -$374.1M -$36.48 $3.7M -1143.7% 175.6%
FY2024 $56.6M -$72.8M -$0.61 $19.3M -147.4% 45.2%
FY2023 $46.7M -$114.3M -$1.28 -$20.7M -225.6% 150.7%
FY2022 $38.0M -$23.4M -$0.00 -$21.3M -133.1% -74.1%
FY2021 $31.3M $783.4K $0.00 -$801.3K -3.2% -1.0%
FY2020 $23.6M -$47.5M -$0.00 -$31.5M -149.7% 78.3%
FY2019 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Scilex Holding Co revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Scilex Holding Co returns on capital have been average, hovering around 8.6% ROIC over the decade.

Scilex Holding Co capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Scilex Holding Co is modeled at 5.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.00 per share.

SCLX stock: frequently asked questions

What is the intrinsic value of Scilex Holding Co. (SCLX) stock?

Graham's formula only works with positive earnings. Scilex Holding Co. reported diluted EPS of -$36.48 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Scilex Holding Co. generate free cash flow?

Scilex Holding Co. generated $3.7M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 2 of the last 6 reported years.

What is SCLX's return on invested capital?

Average ROIC over the last 7 fiscal years was 62.5%, and average return on equity was 52.0%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this SCLX data come from?

From Scilex Holding Co.'s annual 10-K filings on SEC EDGAR, most recently filed May 20, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar biological products stocks